| Authors: |
Costa LJ; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. ljcosta@uabmc.edu., Banerjee R; Division of Hematology and Oncology, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, USA., Mian H; Department of Oncology, McMaster University, Hamilton, ON, Canada., Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bal S; Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Derman BA; Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL, USA., Htut MM; Division of Myeloma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Cancer Center, Duarte, CA, USA., Nagarajan C; Singapore General Hospital, Singapore, Singapore., Rodriguez C; Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA., Richter J; Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA., Frigault MJ; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Ye JC; MD Anderson Cancer Center, University of Texas, Houston, TX, USA., van de Donk NWCJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Voorhees PM; Levine Cancer Institute, Atrium Health Wake Forest Baptist, Charlotte, NC, USA., Puliafito B; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Bahlis N; Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, Alberta, Canada., Popat R; NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK., Chng WJ; National University Cancer Institute, Singapore, National University Health System; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Ho PJ; Royal Prince Alfred Hospital and University of Sydney, Sydney, NSW, Australia., Kaur G; Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA., Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Du J; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Navy Medical University, Shanghai, China., Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway., Berdeja J; Greco-Hainsworth Centers for Cancer Research, Tennessee Oncology, Nashville, TN, USA., Einsele H; Department of Internal Medicine II, University Hospital, Wurzburg, Germany., Cohen AD; University of Pennsylvania, Philadelphia, Pennsylvania, PA, USA., Mikhael J; Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ, USA.; International Myeloma Foundation, Studio City, CA, USA., Biru Y; International Myeloma Foundation, Studio City, CA, USA., Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Martin TG; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Chari A; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. |
